Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Cardiff Oncology (TROV) News Today

Cardiff Oncology logo
Cardiff Oncology publishes onvansertib combination data in journal
Craig-Hallum Sticks to Its Buy Rating for Cardiff Oncology (CRDF)
Cardiff Oncology (NASDAQ: CRDF)
Cardiff Oncology
Cardiff Oncology: Staying The Course
Cardiff Oncology, Inc. (CRDF)
CRDF Cardiff Oncology, Inc.
Cardiff Oncology: Down But Not Out
Get Cardiff Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for TROV and its competitors with MarketBeat's FREE daily newsletter.

Watch this before it gets removed (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

TROV Media Mentions By Week

TROV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TROV
News Sentiment

0.00

0.45

Average
Medical
News Sentiment

TROV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TROV Articles
This Week

1

0

TROV Articles
Average Week

Get Cardiff Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for TROV and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TROV) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners